Trichosanthin, an Extract of Trichosanthes kirilowii, Effectively Prevents Acute Rejection of Major Histocompatibility Complex–Mismatched Mouse Skin Allograft-Reference-Cited by-同舟云学术

Trichosanthin, an Extract of Trichosanthes kirilowii, Effectively Prevents Acute Rejection of Major Histocompatibility Complex–Mismatched Mouse Skin Allograft

Published:2008-12 Issue:10 Volume:40 Page:3714-3718
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Gong Q.,Deng D.,Ding J.,Wang C.,Bian Z.,Ye Z.,Xu J.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference22 articles.

1. Strategies to improve long-term outcomes after renal transplantation;Pascual;N Engl J Med,2002

2. Purification and characterization of trichosanthin;Maraganore;J Biol Chem,1987

3. Homology of trichosanthin and ricin A chain;Zhang;Nature,1986

4. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage;McGrath;Proc Natl Acad Sci U S A,1989

5. Selective killing of choriocarcinoma cells in vitro by trichosanthin, a plant protein purified from root tubers of the Chinese medicinal herb Trichosanthes kirilowii;Tsao;Toxicon,1986

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bio-soft matter derived from traditional Chinese medicine: Characterizations of hierarchical structure, assembly mechanism, and beyond;Journal of Pharmaceutical Analysis;2024-06

2. Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization;International Immunopharmacology;2023-12

3. Chinese Medicine Protein and Peptide in Gene and Cell Therapy;Current Protein & Peptide Science;2019-01-01

4. Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein;Toxins;2018-08-20

5. Trichosanthes kirilowil Exerts Androgenic Activity via Regulation of PSA and KLK2 in 22Rv1 Prostate Cancer Cells;PHARMACOGN MAG;2017